Filtered By:
Vaccination: Influenza Vaccine
This page shows you your search results in order of relevance. This is page number 14.
Order by Relevance | Date
Total 364 results found since Jan 2013.
Potential risk of repeated nasal vaccination that induces allergic reaction with mucosal IgE and airway eosinophilic infiltration in cynomolgus macaques infected with H5N1 highly pathogenic avian influenza virus.
Abstract
The efficacy and detrimental effect of mucosal vaccination with an inactivated influenza vaccine were examined in a macaque model by intranasal administration with small amounts of inactivated whole virus particles and challenge by a human-derived H5N1 highly pathogenic avian influenza virus infection. Repeated nasal inoculation with the whole particle vaccine of an inactivated virus, A/duck/Hokkaido/Vac-3/2007 (H5N1) (Vac-3), induced antigen-specific IgA and IgG antibody production in nasal swabs and plasma. Vac-3-specific IgE production was also found in the nasal swabs. Nasal vaccination with Vac-3 ind...
Source: Vaccine - January 17, 2017 Category: Allergy & Immunology Authors: Nakayama M, Itoh Y, Shichinohe S, Nakabayashi R, Ishigaki H, Sakoda Y, Le QM, Kawaoka Y, Kida H, Ogasawara K Tags: Vaccine Source Type: research
Workshop report: Immunoassay standardisation for “universal” influenza vaccines
This article is protected by copyright. All rights reserved.
Source: Influenza and Other Respiratory Viruses - January 31, 2017 Category: Virology Authors: Sophia Pavlova, Flavia D'Alessio, Sophie Houard, Edmond J. Remarque, Norbert Stockhofe, Othmar G Engelhardt Tags: Meeting Report Source Type: research
A clinical trial of intradermal and intramuscular seasonal influenza vaccination in patients with atopic dermatitis
Antibody responses to the inactivated seasonal influenza vaccine in patients with atopic dermatitis (AD) have not been carefully characterized.
Source: Journal of Allergy and Clinical Immunology - February 12, 2017 Category: Allergy & Immunology Authors: Donald Y.M. Leung, Brett Jepson, Lisa A. Beck, Jon M. Hanifin, Lynda C. Schneider, Amy S. Paller, Katherine Monti, Gloria David, Jennifer Canniff, Margarita Gomez Lorenzo, Adriana Weinberg Source Type: research
CDC: Flu Activity Continues in US, Vaccine 50% Effective CDC: Flu Activity Continues in US, Vaccine 50% Effective
Influenza activity has been ' moderate ' thus far, and severity indicators are in the range seen in prior seasons dominated by influenza A (H3N2) viruses, health officials say.Medscape Medical News
Source: Medscape Allergy Headlines - February 16, 2017 Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news
CDC: Flu Activity Continues in US, Vaccine 48% Effective CDC: Flu Activity Continues in US, Vaccine 48% Effective
Influenza activity has been ' moderate ' thus far, and severity indicators are in the range seen in prior seasons dominated by influenza A (H3N2) viruses, health officials say.Medscape Medical News
Source: Medscape Allergy Headlines - February 16, 2017 Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news
FDA Committee Selects 2017-2018 Influenza Vaccine Strains FDA Committee Selects 2017-2018 Influenza Vaccine Strains
An FDA advisory committee voted to leave the influenza vaccine strains for the 2017-2018 season largely unchanged from those of the previous season.Medscape Medical News
Source: Medscape Allergy Headlines - March 10, 2017 Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news
A clinical trial of intradermal and intramuscular seasonal influenza vaccination in patients with atopic dermatitis
Antibody responses to the inactivated seasonal influenza vaccine in patients with atopic dermatitis (AD) have not been carefully characterized.
Source: Journal of Allergy and Clinical Immunology - February 13, 2017 Category: Allergy & Immunology Authors: Donald Y.M. Leung, Brett Jepson, Lisa A. Beck, Jon M. Hanifin, Lynda C. Schneider, Amy S. Paller, Katherine Monti, Gloria David, Jennifer Canniff, Margarita Gomez Lorenzo, Adriana Weinberg Source Type: research
It's a lot of work to be nonallergic
Edward Jenner developed the first successful vaccine based on the observation that persons exposed to poxvirus pathogens who did not succumb to the disease became protected from further encounters.1 In more recent trials, much has been learned about correlates of health and protection from controlled challenges in patients with infectious diseases as diverse as influenza and malaria, in which the study of exposed subjects who mount an appropriate immune response might hold the key to development of treatment and vaccination alike.
Source: Journal of Allergy and Clinical Immunology - December 16, 2016 Category: Allergy & Immunology Authors: Alessandro Sette, V éronique Schulten Tags: Editorial Source Type: research
Narcolepsy More Prevalent in Influenza-vaccinated Youth in Norway Narcolepsy More Prevalent in Influenza-vaccinated Youth in Norway
Norwegian registry data confirm reports of an association between vaccination during the 2009 influenza A (H1N1) pandemic and subsequent development of narcolepsy in young people, according to researchers.Reuters Health Information
Source: Medscape Allergy Headlines - March 31, 2017 Category: Allergy & Immunology Tags: Neurology & Neurosurgery News Source Type: news
Live attenuated influenza vaccine use and safety in children and adults with asthma
Live attenuated influenza vaccine (LAIV) might increase the risk of wheezing in persons with asthma or children younger than 5 years with a history of recurrent wheezing.
Source: Annals of Allergy, Asthma and Immunology - April 1, 2017 Category: Allergy & Immunology Authors: Jonathan Duffy, Melissa Lewis, Theresa Harrington, Roger Baxter, Edward A. Belongia, Lisa A. Jackson, Steven J. Jacobsen, Grace M. Lee, Allison L. Naleway, James Nordin, Matthew F. Daley, Vaccine Safety Datalink Tags: Original Article Source Type: research
Variation in Occupational Influenza Vaccination Coverage
Wide variation by state in vaccination coverage among tier 1 and health care personnel groups
Source: Pulmonary Medicine News - Doctors Lounge - April 4, 2017 Category: Respiratory Medicine Tags: Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nursing, Oncology, ENT, Pathology, Pediatrics, Pharmacy, Pulmonology, Journal, Source Type: news
How Common is α -1-Antitrypsin Deficiency?
Discussion
α-1-Antitrypsin Deficiency (A1AT) is a common single-gene mutation disease that is homozygous recessive. The normal allele is called M and the most common abnormal allele is Z. There are other alleles though. The gene codes for one of the primary protease inhibitors in the serum, thus those who are homozygous for the Z gene are sometimes referred to as “PIZZ” or “PIZ.” α-1-Antitrypsin is found in all body tissues but is especially important in the serum and lung. As noted it is one of the primary neutrophil protease inhibitors in the serum, and acts to neutralize these enzymes...
Source: PediatricEducation.org - April 24, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
The World Is Not Ready for the Next Pandemic
Across China, the virus that could spark the next pandemic is already circulating. It’s a bird flu called H7N9, and true to its name, it mostly infects poultry. Lately, however, it’s started jumping from chickens to humans more readily–bad news, because the virus is a killer. During a recent spike, 88% of people infected got pneumonia, three-quarters ended up in intensive care with severe respiratory problems, and 41% died.
What H7N9 can’t do–yet–is spread easily from person to person, but experts know that could change. The longer the virus spends in humans, the better the chance that i...
Source: TIME.com: Top Science and Health Stories - May 4, 2017 Category: Consumer Health News Authors: Bryan Walsh Tags: Uncategorized CDC Disease ebola Gates Foundation MERS outbreak pandemic Zika Source Type: news
Four-week Methotrexate Break Improves Flu Shot Response in RA Patients Four-week Methotrexate Break Improves Flu Shot Response in RA Patients
Temporarily withholding methotrexate (MTX) can improve the efficacy of seasonal influenza vaccination in patients with rheumatoid arthritis (RA), according to a new randomized clinical trial.Reuters Health Information
Source: Medscape Allergy Headlines - May 18, 2017 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news
NIH scientists find real-time imaging in mice a promising influenza study tool
(NIH/National Institute of Allergy and Infectious Diseases) Real-time imaging of influenza infection in mice is a promising new method to quickly monitor disease progression and to evaluate whether candidate vaccines and treatments are effective in this animal model, according to scientists from NIAID. They evaluated the live imaging system as a potential alternative to traditional methods of assessing investigative influenza vaccines and treatment in mice, which can be time consuming and require more study animals for valid statistical comparison.
Source: EurekAlert! - Infectious and Emerging Diseases - May 30, 2017 Category: Infectious Diseases Source Type: news
